(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -218.40%-36.06K | 25.04%-11.11K | 63.04%-44.02K | 73.29%-4.38K | 78.10%-13.49K | 37.25%-11.33K | 35.76%-14.82K | 49.60%-119.13K | -223.10%-16.41K | -1,752.67%-61.6K |
Net income from continuing operations | -231.70%-208.5K | -28.57%-85.75K | 4.13%-242.45K | -25.20%-62.99K | 23.01%-49.91K | 20.34%-62.86K | -13.32%-66.69K | 28.57%-252.89K | 58.71%-50.31K | -7.23%-64.82K |
Remuneration paid in stock | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -67.94%20.04K | --0 | --0 |
Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -416.71%-10.05K | --0 | ---753 |
Change In working capital | 64.80%84.93K | 43.89%74.64K | 60.31%198.42K | 72.88%58.61K | 815.20%36.42K | 2.83%51.53K | 44.96%51.87K | 116.64%123.78K | -37.54%33.9K | -93.80%3.98K |
-Change in receivables | -831.92%-7.47K | 8,666.67%1.05K | -147.78%-237 | -138.78%-617 | -30.65%1.17K | 74.43%-802 | -96.62%12 | -79.76%496 | 342.16%1.59K | -92.66%1.69K |
-Change in prepaid assets | 0.00%-9.38K | 0.00%3.13K | --0 | 0.00%3.13K | 0.00%3.13K | 18.18%-9.38K | --3.13K | ---5.21K | --3.13K | -37.50%3.13K |
-Change in payables and accrued expense | 64.93%101.77K | 44.59%70.46K | 54.61%198.66K | 92.22%56.1K | 3,956.06%32.12K | -4.64%61.71K | 37.56%48.73K | 134.97%128.49K | -46.87%29.18K | -102.30%-833 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -218.40%-36.06K | 25.04%-11.11K | 63.04%-44.02K | 73.29%-4.38K | 78.10%-13.49K | 37.25%-11.33K | 35.76%-14.82K | 49.60%-119.13K | -223.10%-16.41K | -1,752.67%-61.6K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | -35K | -60.28%6.98K | 0 | -94.56%6.98K | 0 | 0 | 102.79%17.57K | -2,211.65%-50K | 417.48%128.35K |
Capital expenditure reported | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 77.02%-144.53K | ---50K | ---33.75K |
Net PPE purchase and sale | --0 | ---35K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net other investing changes | ---- | ---- | -95.70%6.98K | --0 | ---- | ---- | ---- | --162.1K | --0 | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | ---35K | -60.28%6.98K | --0 | -94.56%6.98K | --0 | --0 | 102.79%17.57K | -2,211.65%-50K | 417.48%128.35K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 0 | -92.37%60.3K | 0 | 0 | ||||
Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -91.63%60.3K | --0 | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -92.37%60.3K | --0 | --0 |
Net cash flow | ||||||||||
Beginning cash position | -96.05%2.81K | -43.09%48.92K | -32.43%85.97K | -65.02%53.3K | -30.14%59.82K | -31.69%71.14K | -32.43%85.97K | -37.19%127.23K | 13.32%152.38K | -48.16%85.63K |
Current changes in cash | 576.32%53.95K | -211.08%-46.11K | 10.21%-37.05K | 93.40%-4.38K | -109.76%-6.52K | 38.87%-11.33K | 35.76%-14.82K | 45.23%-41.26K | -817.03%-66.41K | 317.43%66.75K |
End cash Position | -5.12%56.76K | -96.05%2.81K | -43.09%48.92K | -43.09%48.92K | -65.02%53.3K | -30.14%59.82K | -31.69%71.14K | -32.43%85.97K | -32.43%85.97K | 13.32%152.38K |
Free cash from | -218.40%-36.06K | -211.08%-46.11K | 83.30%-44.02K | 93.40%-4.38K | 85.85%-13.49K | 85.63%-11.33K | 35.76%-14.82K | 69.53%-263.66K | -817.03%-66.41K | -159.80%-95.35K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data